Characterising and treating osteogenesis imperfecta

Early Human Development

Volumn 86, Issue 11, 2010, Pages 743-746

  Bishop, Nick ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Bisphosphonates; Bone density; Fractures; Infant; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; BISPHOSPHONIC ACID DERIVATIVE; ENB 0040; PAMIDRONIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BONE BOWING; CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FAMILY HISTORY; FETUS ECHOGRAPHY; FRACTURE; GENE MUTATION; HUMAN; HYPOPHOSPHATASIA; OCCUPATIONAL THERAPY; OSTEOGENESIS IMPERFECTA; OSTEOPOROSIS; OUTCOME ASSESSMENT; PERINATAL PERIOD; PHYSIOTHERAPY; PROGNOSIS; SCOLIOSIS;

BONE AND BONES; BONE DENSITY CONSERVATION AGENTS; COLLAGEN TYPE I; DIAGNOSIS, DIFFERENTIAL; DIPHOSPHONATES; HUMANS; INFANT; INFANT, NEWBORN; OSTEOGENESIS IMPERFECTA; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES;

EID: 78049259511     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2010.08.002     Document Type: Article

References (29)

1. Marini JC, Cabral WA, Barnes AM. Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta. Cell Tissue Res 2010; 339(1):59-70.
2. Sillence D.O., Senn A., Danks D.M. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 1979, 16(2):101-116.
3. van Dijk F.S., Nesbitt I.M., Zwikstra E.H., Nikkels P.G., Piersma S.R., Fratantoni S.A., et al. PPIB mutations cause severe osteogenesis imperfecta. Am J Hum Genet 2009, 85(4):521-527.
4. Christiansen HE, Schwarze U, Pyott SM, AlSwaid A, Al Balwi M, Alrasheed S,. Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta. Am J Hum Genet 2010; 86(3):389-98.
5. Alanay Y, Avaygan H, Camacho N, Utine GE, Boduroglu K, Aktas D, Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta. Am J Hum Genet 2010; 86(4):551-9.
6. Byers P.H. Collagens: building blocks at the end of the development line. Clin Genet 2000, 58(4):270-279.
7. Turner C.H., Burr D.B. Basic biomechanical measurements of bone: a tutorial. Bone 1993, 14(4):595-608.
8. Rauch F., Travers R., Plotkin H., Glorieux F.H. The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Invest 2002, 110(9):1293-1299.
9. Marini J.C., Forlino A., Cabral W.A., et al. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat 2007, 28(3):209-221.
10. Marini J.C., Cabral W.A., Barnes A.M., Chang W. Components of the collagen prolyl 3-hydroxylation complex are crucial for normal bone development. Cell Cycle 2007, 6(14):1675-1681.
11. Barnes AM, Carter EM, Cabral WA, Weis M, Chang W, Makareeva E, Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding. N Engl J Med 2010; 362(6):521-8.
12. Barnes A.M., Chang W., Morello R., et al. Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. N Engl J Med 2006, 355(26):2757-2764.
13. Cabral W.A., Chang W., Barnes A.M., et al. Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta. Nat Genet 2007, 39(3):359-365.
14. Morello R., Bertin T.K., Chen Y., et al. CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 2006, 127(2):291-304.
15. Labuda M., Morissette J., Ward L.M., et al. Osteogenesis imperfecta type VII maps to the short arm of chromosome 3. Bone 2002, 31(1):19-25.
16. Ward L.M., Rauch F., Travers R., et al. Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease. Bone 2002, 31(1):12-18.
17. Lapunzina P, Aglan M, Temtamy S, Caparrós-Martín JA, Valencia M, Letón R, Identification of a frameshift mutation in Osterix in a patient with recessive osteogenesis imperfecta. Am J Hum Genet 2010; 87(1):110-4.
18. Glorieux F.H., Rauch F., Plotkin H., et al. Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res 2000, 15(9):1650-1658.
19. Glorieux F.H., Ward L.M., Rauch F., Lalic L., Roughley P.J., Travers R. Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res 2002, 17(1):30-38.
20. Waller S., Kurzawinski T., Spitz L., et al. Neonatal severe hyperparathyroidism: genotype/phenotype correlation and the use of pamidronate as rescue therapy. Eur J Pediatr 2004, 163(10):589-594.
21. Bishop N., Sprigg A., Dalton A. Unexplained fractures in infancy: looking for fragile bones. Arch Dis Child 2007, 92(3):251-256.
22. Antoniazzi F., Zamboni G., Lauriola S., Donadi L., Adami S., Tato L. Early bisphosphonate treatment in infants with severe osteogenesis imperfecta. J Pediatr 2006, 149(2):174-179.
23. Astrom E., Jorulf H., Soderhall S. Intravenous pamidronate treatment of infants with severe osteogenesis imperfecta. Arch Dis Child 2007, 92(4):332-338.
24. Chien Y.H., Chu S.Y., Hsu C.C., Hwu W.L. Pamidronate treatment of severe osteogenesis imperfecta in a newborn infant. J Inherit Metab Dis 2002, 25(7):593-595.
25. DiMeglio L.A., Ford L., McClintock C., Peacock M. Intravenous pamidronate treatment of children under 36months of age with osteogenesis imperfecta. Bone 2004, 35(5):1038-1045.
26. Plotkin H., Rauch F., Bishop N.J., et al. Pamidronate treatment of severe osteogenesis imperfecta in children under 3years of age. J Clin Endocrinol Metab 2000, 85(5):1846-1850.
27. Senthilnathan S., Walker E., Bishop N.J. Two doses of pamidronate in infants with osteogenesis imperfecta. Arch Dis Child 2008, 93(5):398-400.
28. Hasegawa K., Inoue M., Seino Y., Morishima T., Tanaka H. Growth of infants with osteogenesis imperfecta treated with bisphosphonate. Pediatr Int 2009, 51(1):54-58.
29. Munns C.F., Rauch F., Mier R.J., Glorieux F.H. Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta. Bone 2004, 35(1):231-234.